Your browser doesn't support javascript.
loading
Increased circulating progranulin is not sufficient to induce cardiac dysfunction or supraventricular arrhythmia.
McElhanon, Kevin E; Huff, Tyler C; Hirenallur-Shanthappa, Dinesh; Miller, Russell A; Christoforou, Nicolas.
Afiliação
  • McElhanon KE; Rare Disease Research Unit, Worldwide Research, Development, and Medical, Pfizer, Inc., Cambridge, MA, USA.
  • Huff TC; Rare Disease Research Unit, Worldwide Research, Development, and Medical, Pfizer, Inc., Cambridge, MA, USA.
  • Hirenallur-Shanthappa D; Comparative Medicine, Worldwide Research, Development, and Medical, Pfizer, Inc., Cambridge, MA, USA. DineshH@pfizer.com.
  • Miller RA; Rare Disease Research Unit, Worldwide Research, Development, and Medical, Pfizer, Inc., Cambridge, MA, USA.
  • Christoforou N; Rare Disease Research Unit, Worldwide Research, Development, and Medical, Pfizer, Inc., Cambridge, MA, USA. nchristoforou@gmail.com.
Sci Rep ; 13(1): 21541, 2023 12 06.
Article em En | MEDLINE | ID: mdl-38057339
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article